Design Transfer according to ISO 13485:2016: From Development to Medical-Device Production

Design and development, which culminate in design transfer, are pivotal stages in the life cycle of a medical device. Design transfer is the vital link between innovation, regulatory compliance, and production control, opening the way to full-scale manufacturing. Beyond a straightforward hand-off from R&D to manufacturing, design transfer is a structured process that ensures the product can be manufactured repeatedly, reliably, and in full compliance with regulatory and internal requirements.

1. The concept of design transfer under ISO 13485:2016

ISO 13485:2016, clause 7.3.8, states that “the organization shall document procedures for transfer of design and development outputs to manufacturing”. These procedures must ensure that the design outputs (DO), including drawings, specifications, quality-control methods, and so on, are fit for manufacture before they become the final production specifications, and that the intended production resources can meet all product requirements.

In practical terms, design transfer is the controlled hand-off of all the information needed to move from R&D to manufacturing, shifting from ad-hoc builds (prototypes, pilot runs, small batches) to validated, routine production through industrialization.

2. Key Stages of Design Transfer

Design transfer can begin as soon as the DO are finalized, namely once R&D has completed the Product Specifications. The process then involves:

• Confirming that the specifications are manufacturable
• Factoring in production-related constraints and requirements (regulatory, quality, industrial feasibility)
• Managing, step by step, the industrial ramp-up: equipment qualification, process validation, documentation, operator training, and more.

To keep the transition smooth and avoid costly rework, manufacturing constraints must be addressed as early as the design-input (DI) phase. For example, if the finished product must run on existing production lines, the design must avoid technologies that are not already available on site.

Early involvement of industrialization, methods, engineering, and production specialists, during both the development and design-planning phases, is an important factor in the success of the project. Equally important is raising production teams’ awareness of design and development requirements, so that communication stays fluid and everyone shares a clear understanding of project goals.

3. Establishing and Managing Requirements and Documentation

Design and manufacturing requirements, including quality and regulatory obligations, must be clearly defined at the very start of the project. Once established, the DO serve as the inputs for industrialization. Acceptance criteria must be set, and any deviation managed rigorously through action plans, procedural adjustments, or, if necessary, redesign*.

Every one of these design and manufacturing requirements, including drawings, specifications, methods, control plans, work instructions, and procedures, must be documented, kept continuously up to date, and systematically approved in line with the established process.

*Note: When a redesign is required, it is essential to carefully track, document, and control all changes and their impacts (change control).

4. Typical activities and their timeline

Design transfer is a planned sequence of technical, quality, and regulatory activities intended to turn a concept validated by R&D into a product that can be manufactured under full industrial control. The indicative timeline below lists the main design-transfer activities. The order and duration of these activities may vary depending on the project, the product, and the level of industrial maturity of the manufacturer:

• Product specifications (R&D): Technical description of the product, drawings, functional specifications, and inspection methods.
• Process FMEA (Failure Modes and Effects Analysis): Analysis of potential failure modes and their effects to anticipate industrial risks.
• Definition of critical parameters (based on the FMEA): Which factors (temperature, pressure, time, environmental conditions) influence product quality?
• Identification of control tests for process validation: Which steps are critical to demonstrate that the manufacturing process is under control?
• Development of test methods: Drafting and qualifying methods for quality, robustness, and performance testing.
• Drafting of work instructions: Step-by-step instructions for each manufacturing stage, standardising know-how.
• Operator training/qualification: Ensuring the team acquires the necessary practical and theoretical skills.
• Equipment qualification: IQ (Installation Qualification), OQ (Operational Qualification), PQ (Performance Qualification).
• Process validation: Preparation of validation protocols and definition of pilot batches.
• Identification of routine control tests: Which inspections will be performed on each batch? At incoming inspection? In-process during production? Or on the finished product?
• Product specifications (production): Production-ready version integrating logistics and traceability requirements.
• Installation, maintenance, and servicing procedures: Documenting the ancillary activities needed to sustain the manufacturing process.

• Compilation of all elements in the DMR (Device Master Record): This master document constitutes the device’s manufacturing file. It gathers every dossier containing the documents listed above (specifications, procedures, qualification/validation records, test methods, etc.).

Collectively, these activities form the backbone of design transfer, ensuring every requirement is translated into a robust industrial process before routine production begins.

5. Examples of Industrial Contexts and Sample Representativeness

Before a process is finally validated, evidence must demonstrate that the parts or lots evaluated faithfully mirror future full-scale production. This verification and validation work spans a wide spectrum of settings, including one-off builds, short runs, high-volume automated lines, and niche technologies. Understanding these environments and selecting representative samples give real meaning to the collected data and, ultimately, secure robust design transfer.

As a project progresses, the maturity of evaluated parts evolves. The sequence typically begins with prototypes that confirm technical principles, then moves to pilot or pre-series lots to prove process repeatability on equipment identical – or very close – to the future production line. The technology that is applied shapes this sequence as well. In plastics processing, for instance, a component’s robustness hinges on thermoplastic flow inside the mould, so final checks must wait until the production mould is received and qualified.

Certain disciplines impose specific constraints. Biological testing, integrated into verification, requires a product strictly representative of the commercial configuration, because final packaging and trace manufacturing residues can influence biocompatibility. Anticipating the availability of such samples prevents bottlenecks and schedule slips.

Production volume also plays a decisive role. For a patient-specific device or a single batch, lighter process validation such as offset by reinforced in-process controls may suffice. Conversely, large-scale manufacturing demands full equipment qualification and statistically rigorous process validation to guarantee long-term repeatability.

This diversity of scenarios introduces recurring grey areas that can undermine the overall approach, and even the best-constructed timelines can remain vulnerable to familiar misinterpretations and pitfalls.

6. Common Misconceptions and Pitfalls to Avoid

Even a meticulously planned design transfer can be undermined by a handful of recurring misconceptions, putting market launch at risk or causing costly delays. The points below highlight the most common sources of confusion to help anticipate and prevent these before they occur:

• Technical feasibility vs. industrial feasibility: Technical feasibility (prototypes, early bench tests) does not automatically ensure industrial feasibility (routine, high-volume production).
• Design outputs vs. DMR: DO may include a broad set of development deliverables including DMR, but this Master Record is not finalized until design transfer is complete. During the DO phase, deliverables are R&D-level specifications, which often differ from production documents. For instance, a raw-material specification may not yet include detailed logistics (palletizing, packaging, shipping) or the supplier’s finalized change-control agreements (Regulatory Affairs/Quality Assurance). These become mandatory once routine production under ISO 13485:2016 begins.
• Design validation vs. process validation: Design validation confirms the product meets user needs (ISO 13485:2016 § 7.3.7); process validation demonstrates that the manufacturing line can consistently produce conforming product at scale (ISO 13485:2016 § 7.5.6).
• Verification vs. validation: Verification can occur before all production equipment is in place, whereas validation must be performed on product representative of the final device, manufactured with the definitive production means.
• Qualification vs. validation:
  • Qualification shows that equipment and processes (IQ/OQ/PQ) can achieve intended performance—for example, qualifying a plastic injection press through Installation, Operational, and Performance Qualification.
  • Process validation confirms the process can routinely manufacture product to specification.
• Production transfer vs. design transfer: Relocating a line or site triggers a new round of design-transfer activities under formal change control, to re-establish and document the manufacturing framework in the new environment.

A clear grasp of these distinctions supported by appropriate tracking tools is essential to prevent delays, cost overruns, and non-conformities.

7. Document Control and Supplier or Sub-Contractor Activities

The company’s responsibility covers all manufacturing activities, including those performed at its own sites as well as any outsourced processes carried out by external providers and subcontractors. ISO 13485:2016 requires evidence that production relies on (1) properly qualified equipment, (2) fully validated processes, and (3) documentation that is both current and formally approved.

That proof must remain valid whether manufacturing is performed in-house or outsourced. The contracting organization therefore has to maintain a monitoring system that both (a) checks equipment qualification and process validation at each supplier and (b) ensures every document, including specifications, work instructions, and inspection procedures circulates in its latest, up-to-date version duly approved by both parties. Robust document control also means complete traceability of production records and a formal change-management process. Any change request issued by a supplier must follow an approval workflow defined in the quality agreement.

Suppliers must mirror the internal controls applied by the manufacturer: audits, raw-material qualification, process validation, quality checks, and contractual documentation. For example, ISO 13485:2016-compliant change control at the supplier site must be written into the quality agreement between both parties. This approach keeps the entire supply chain aligned with product requirements and regulatory expectations.

8. Iterations and Feedback Loops: Managing Deviations and Adapting the Design

When developing a new product, it is common to revisit the DO (product specifications) and even the DI (re-evaluating requirements in light of constraints uncovered during verification and validation).

Every one of these back-and-forth steps must be formally documented, justified, and approved: record the modification, perform a regulatory impact assessment, update every part of the industrialization file, and, where relevant, repeat verification or validation. The challenge is to transform these iterative cycles into drivers of optimization rather than sources of delay, ensuring each adjustment enhances patient safety, reduces risk, and reinforces regulatory compliance. Achieving this depends on transparent project governance, seamless communication among R&D, Quality Assurance, Regulatory Affairs, Manufacturing, and suppliers, and dynamic planning that smoothly integrates necessary changes. In this way, the design evolves in a controlled manner, supporting the market launch of a reliable and compliant product.

Conclusion

Design transfer, governed by ISO 13485:2016, is a pivotal stage that bridges innovation and everyday manufacturing. It demands rigorous documentation, a multidisciplinary mindset, continuous quality involvement at every step, and early, thorough consideration of manufacturing constraints during product design. The success of this phase depends as much on product robustness as on process maturity and the upkeep of the resulting documentation. Mastering every detail of the activities and requirements of design transfer is the key to controlled production that meets all expectations of patients and regulatory authorities.

Need assistance?

Our R&D teams can help you keep your design file fully compliant with ISO 13485:2016 and with Chapter II of Annex I of the EU MDR 2017/745 and EU IVDR 2017/746, offering comprehensive regulatory and methodological support.

We can assist with the following services:

• Assessment of existing documentation,
• Training on design and development following ISO 13485:2016 (1 or 2 days depending on the need), offered virtually or in-person,
• Writing of reports and documentation in compliance with regulatory and normative requirements,
• Operational support by one or more consultant(s), overseen by senior Subject Matter Experts, including a posteriori design control for legacy products if needed,
• State-of-the-art literature reviews during the development phase to determine intended uses, indications, and product claims,

Contact the Solution & Project Delivery for targeted solutions to your project challenges: solutionprojectdelivery@efor-group.com.